Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Marketing suspension of Hexavac recommended by the EMEA

Sep. 21, 2005

Novel immunomodulating agents revealed in patents

Sep. 19, 2005

Immunosuppressant S1P1 receptor agonists prepared and tested at Merck & Co.

Sep. 12, 2005

Mechanisms underlying SERP-1 mediated inhibition of monocytic adhesion and migration

Sep. 12, 2005

CYC-10268 targets macrophage survival in vitro

Sep. 9, 2005

Hemispherx reports preclinical studies on dsRNA

Sep. 8, 2005

Canadian phase II study for ragweed allergy vaccine

Sep. 8, 2005

Proquad approved to protect children from measles, mumps, rubella & varicella

Sep. 7, 2005

Biken receives Japanese approval for combined measles-rubella vaccine

Sep. 6, 2005

Novel immunosuppressant agents claimed by 4 AZA Bioscience

Sep. 2, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026